GKOS Stock Cash Flow Statements

Glaukos Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Glaukos Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30

operating activities
net income	-19,657,000	-18,146,000	-33,580,000	-21,409,000	-50,545,000	-40,838,000	-36,779,000	-30,444,000	-32,812,000	-34,626,000	-31,460,000	-27,576,000	-45,536,000	5,377,000	-21,872,000	6,230,000	-17,482,000	-16,469,000	-10,648,000	-15,748,000	-39,894,000	-54,058,000	36,581,000	-13,506,000	-6,309,000	-1,342,000	1,779,000	-6,621,000	-5,398,000	-2,711,000		1,325,000	-3,301,000	878,000		1,159,000	2,332,000	897,000	-2,290,000	-2,057,000
adjustments to reconcile net income to net cash from operating activities:
depreciation	2,725,000	2,651,000	2,768,000	2,743,000	2,753,000	2,685,000	2,287,000	2,226,000	2,151,000	2,078,000	1,954,000	1,666,000	1,662,000	1,382,000		1,162,000	1,163,000	1,150,000
amortization of intangible assets	5,844,000	5,576,000	5,972,000	6,256,000	6,245,000	6,228,000	6,228,000	6,228,000	6,228,000	6,228,000	6,228,000	6,228,000	6,228,000	6,228,000		6,228,000	6,228,000	6,228,000
amortization of right-of-use lease assets	1,055,000	1,078,000
amortization of debt issuance costs			56,000	67,000	252,000	343,000	343,000	343,000	344,000	343,000	343,000	343,000	344,000	343,000	343,000	343,000	344,000	343,000
deferred income tax benefit	-8,000	-10,000	-215,000	1,000			-105,000	-9,000	-1,000	-5,000	-37,000	-5,000	-6,000	-6,000	-957,000	-24,000	-24,000	-24,000	-2,836,000	-1,086,000	-7,545,000	-709,000
loss on disposal of fixed assets	5,000	6,000		0															80,000	272,000			404,000	19,000			73,000	5,000	77,000	1,000		0
stock-based compensation	18,019,000	12,986,000	13,309,000	14,420,000	11,313,000	11,165,000	12,987,000	10,484,000	9,873,000	10,184,000	11,688,000	9,411,000	10,539,000	6,923,000	7,225,000	6,189,000	7,984,000	8,748,000	8,744,000	9,660,000	10,897,000	17,176,000	12,470,000	8,547,000	8,247,000	7,129,000	6,668,000	7,173,000	6,461,000	5,402,000		4,718,000	4,733,000	3,202,000		2,652,000	2,048,000	1,417,000	1,558,000	1,552,000
unrealized foreign currency losses	2,486,000	1,397,000	4,130,000	-2,421,000	1,455,000	1,456,000		894,000	283,000	-186,000	-1,977,000	1,950,000			477,000	1,009,000	-274,000	1,101,000				2,024,000	-275,000			87,000	106,000	356,000
amortization of premium on short-term investments	-1,050,000	-1,149,000		-962,000	-1,114,000	-1,111,000		-699,000	-287,000	-55,000	130,000	159,000	206,000	236,000																-58,000		-3,000	31,000	27,000		45,000	79,000	82,000
other liabilities	1,906,000	-1,091,000	312,000	1,398,000	970,000	2,526,000	818,000	-122,000	1,669,000	684,000			118,000	-163,000	514,000	400,000	981,000	570,000		1,019,000	2,117,000	207,000
acquired in-process r&d acquired through the issuance of common stock			0	0	0	5,000,000	0	0
inducement expense related to exchange of convertible senior notes			0	0
allowance for doubtful accounts	2,700,000	1,367,000
changes in operating assets and liabilities:
accounts receivable	-11,668,000	-12,316,000	-5,490,000	-4,462,000	-4,908,000	-7,106,000	-308,000	-435,000	-1,449,000	-1,651,000	-17,000	175,000	-1,873,000	-1,423,000	1,206,000	2,173,000	-1,132,000	-547,000	-3,386,000	-5,927,000	2,310,000	9,246,000	-804,000	-2,475,000	-1,394,000	-1,959,000	957,000	-2,565,000	219,000	-863,000		-194,000	-2,208,000	-81,000		-119,000	-2,069,000	-1,982,000	-575,000	-476,000
inventory	-2,731,000	-1,668,000	-627,000	-3,056,000	-6,554,000	-8,551,000	-1,927,000	-620,000	806,000	-3,089,000	-3,591,000	-6,730,000	-3,401,000	-1,750,000	-3,446,000	-2,394,000	-2,266,000	403,000	-20,616,000	1,182,000	6,828,000	14,568,000	3,664,000	1,166,000	-595,000	-157,000	208,000	215,000	-1,236,000	-1,490,000		-550,000	-830,000	-538,000		-612,000	-450,000	-1,129,000	-948,000	-243,000
prepaid expenses and other current assets	1,420,000	-2,339,000	3,652,000	-3,971,000	4,565,000	-912,000	1,470,000	-887,000	1,030,000	-2,498,000	1,635,000	-2,753,000	67,000	-669,000	1,985,000	-1,281,000	-1,955,000	-1,803,000	-704,000	-2,723,000	629,000	-2,235,000	1,409,000	-2,788,000	635,000	-173,000	-61,000	106,000	-1,093,000	-708,000		-153,000	243,000	478,000		-1,265,000	224,000	-355,000	-7,000	-581,000
accounts payable and accrued liabilities	6,616,000	-6,729,000	4,427,000	565,000	-1,351,000	-3,620,000	7,454,000	3,376,000	-259,000	-9,266,000	9,057,000	-10,214,000	15,945,000	-7,578,000	782,000	-3,658,000	12,301,000	3,023,000	3,458,000	-8,139,000	6,748,000	-4,750,000	839,000	1,951,000	3,123,000	-5,134,000	4,527,000	4,149,000	1,907,000	-8,056,000		629,000	4,461,000	-2,316,000		968,000	2,844,000	-816,000	356,000	-25,000
deposits and other assets	-683,000	-134,000
net cash from operating activities	6,979,000	-18,521,000	507,000	-9,586,000	-18,369,000	-33,870,000	-10,665,000	-8,168,000	-8,161,000	-30,764,000	-4,136,000	-26,515,000	-12,206,000	9,774,000	-4,651,000	17,790,000	7,391,000	4,178,000	10,604,000	-9,570,000	-10,923,000	-13,099,000	-4,191,000	-2,988,000	6,602,000	208,000	17,128,000	4,362,000	4,012,000	-6,638,000		6,991,000	4,262,000	2,376,000		3,929,000	6,039,000	-937,000	-570,000	-557,000
capex	-1,091,000	-1,436,000	-938,000	-1,848,000	-3,212,000	607,000	-6,082,000	-3,239,000	-5,107,000	-4,487,000	-7,682,000	-6,091,000	-8,796,000	-3,899,000	-9,327,000	-9,916,000	-11,360,000	-17,182,000	-2,145,000	-1,281,000	-2,727,000	-782,000	-1,194,000	-1,007,000	-1,872,000	-651,000	-7,582,000	-727,000	-760,000	-1,246,000		-2,382,000	-1,311,000	-760,000		-3,017,000	-842,000	-377,000	-375,000	-183,000
free cash flows	5,888,000	-19,957,000	-431,000	-11,434,000	-21,581,000	-33,263,000	-16,747,000	-11,407,000	-13,268,000	-35,251,000	-11,818,000	-32,606,000	-21,002,000	5,875,000	-13,978,000	7,874,000	-3,969,000	-13,004,000	8,459,000	-10,851,000	-13,650,000	-13,881,000	-5,385,000	-3,995,000	4,730,000	-443,000	9,546,000	3,635,000	3,252,000	-7,884,000		4,609,000	2,951,000	1,616,000		912,000	5,197,000	-1,314,000	-945,000	-740,000
investing activities
cash paid for acquisitions, net of cash acquired
purchase of real estate property
purchases of short-term investments	-42,022,000	-74,743,000	-66,864,000	-32,002,000	-41,839,000	-49,250,000	-72,049,000	-23,468,000	-73,775,000	-96,295,000	-12,000,000	-10,318,000	-20,191,000	-16,747,000	-23,529,000	-94,523,000	-43,226,000	-54,007,000	-27,204,000	-212,915,000	-42,203,000	-18,680,000	-15,662,000	-23,868,000	-24,245,000	-16,613,000	-23,596,000	-22,968,000	-19,213,000	-27,919,000		-25,671,000	-19,167,000	-26,599,000		-24,899,000	-12,115,000	-23,710,000
proceeds from sales and maturities of short-term investments	53,533,000	40,878,000	80,308,000	65,161,000	79,850,000	21,880,000	64,365,000	41,822,000	107,011,000	89,902,000	37,663,000	40,746,000	39,564,000	17,184,000	24,560,000	78,664,000	53,343,000	50,349,000	26,613,000	33,073,000	25,335,000	19,676,000	18,624,000	20,801,000	24,880,000	16,189,000	14,666,000	17,763,000	22,325,000	24,097,000		26,610,000	19,323,000	25,257,000		17,748,000	8,354,000	15,600,000
purchases of property and equipment	-1,179,000	-1,938,000	-1,733,000	-1,450,000	-2,149,000	-968,000	-4,214,000	-3,360,000	-5,766,000	-6,908,000	-8,221,000	-6,039,000	-9,401,000	-6,604,000	-9,327,000	-9,916,000	-11,360,000	-17,182,000	-2,145,000	-1,281,000	-2,727,000	-782,000	-1,194,000	-1,007,000	-1,872,000	-651,000	-7,582,000	-727,000	-760,000	-1,246,000		-2,382,000	-1,311,000	-760,000		-3,017,000	-842,000	-377,000	-375,000	-183,000
proceeds from disposal of property and equipment			0	0							55,000	0	41,000	55,000	0	0
investment in company-owned life insurance	-2,070,000	-395,000	76,000	-1,146,000	-1,036,000	-1,045,000	-1,023,000	-97,000	-1,519,000	-531,000	-842,000	2,000	-383,000	215,000	-576,000	-288,000	-794,000	-423,000	-723,000	-439,000	-1,072,000	414,000				-638,000
other investing activities	0	-750,000
net cash from investing activities	-20,782,000	-36,948,000	11,787,000	30,563,000	34,864,000	-29,383,000	-12,921,000	14,897,000	25,951,000	-13,832,000	16,655,000	24,391,000	9,630,000	-5,897,000	-8,872,000	-26,063,000	-2,034,000	-21,263,000		-181,562,000	-20,667,000	628,000		-4,074,000	-599,000	-1,713,000	-17,752,000	-5,932,000	2,352,000	-5,068,000		-1,443,000	-1,155,000	-2,102,000		-10,168,000	-4,603,000	-8,487,000	-70,126,000	-183,000
financing activities
proceeds from exercise of stock options	4,972,000	4,082,000	9,838,000	5,509,000	10,945,000	13,055,000	6,124,000	4,310,000	1,639,000	675,000	706,000	950,000	1,373,000	548,000	1,741,000	1,559,000	6,272,000	16,552,000	9,938,000	3,668,000	2,136,000	4,454,000	1,059,000	4,834,000	4,564,000	4,607,000	2,236,000	11,812,000	3,154,000	1,452,000		484,000	812,000	1,970,000		1,335,000	1,976,000	438,000	15,000	355,000
proceeds from share purchases under employee stock purchase plan	0	2,961,000		4,729,000	0	2,687,000		4,115,000	0	2,163,000		3,845,000	0	1,785,000		3,268,000	0	1,549,000		2,747,000	0	1,278,000		2,486,000
payment of employee taxes related to vested restricted stock units	-2,449,000	-4,845,000		-328,000	-2,127,000	-2,378,000		-768,000	-2,341,000	-1,537,000		-445,000	-1,136,000	-818,000		-858,000	-1,747,000	-1,065,000		-594,000	-501,000	-1,512,000		-654,000	-4,246,000	-102,000		-7,000
principal paid on finance lease	-278,000	-248,000	-212,000	-242,000	-226,000	-197,000	-194,000	-190,000	-178,000	-149,000	-147,000	-144,000	-131,000	-105,000	-104,000	-102,000	-202,000	-251,000
net cash from financing activities	2,245,000	1,950,000	60,113,000	9,668,000	8,592,000	13,167,000	7,303,000	7,467,000	-880,000	1,152,000	529,000	4,206,000	106,000	1,410,000	1,617,000	3,867,000	16,362,000	17,414,000	8,659,000	5,821,000	243,842,000	4,220,000	-22,036,000	6,666,000	318,000	5,407,000	1,974,000	13,926,000	2,836,000	2,840,000		484,000	1,780,000	1,970,000		-911,000	550,000	-1,703,000	-988,000	-10,075,000
effect of exchange rate changes on cash and cash equivalents	-2,780,000	-1,855,000	-2,924,000	1,423,000	-630,000	-886,000	821,000	-79,000	282,000	317,000	459,000	-667,000	-1,467,000	207,000	-517,000	-759,000	-48,000	-450,000	38,000	-669,000	1,108,000	-565,000	-244,000	-29,000			-32,000	-19,000	154,000	-55,000		-84,000	-138,000	-117,000		-201,000	-39,000	-53,000	-83,000	10,000
net decrease in cash, cash equivalents and restricted cash	-14,338,000	-55,374,000			24,457,000	-50,972,000											21,671,000	-121,000
cash, cash equivalents and restricted cash at beginning of period	0	174,359,000	0	0	0	99,323,000	0	0	0	126,603,000	0	0	0	110,124,000	0	0	0	106,162,000	0	0	0	71,756,000	0	0	0	38,596,000	0	0	0	24,508,000
cash, cash equivalents and restricted cash at end of period	-14,338,000	118,985,000	69,483,000	32,068,000	24,457,000	48,351,000	-15,462,000	14,117,000	17,192,000	83,476,000	13,507,000	1,415,000	-3,937,000	115,618,000	-12,423,000	-5,165,000	21,671,000	106,041,000	15,842,000	-185,980,000	213,360,000	62,940,000	23,341,000	-425,000	6,347,000	42,493,000	1,318,000	12,337,000	9,354,000	15,587,000
supplemental disclosures of cash flow information
taxes paid, net of refunds	235,000	276,000	195,000	364,000	450,000	351,000	339,000	438,000	525,000	255,000
interest paid on convertible senior notes			791,000	0			3,953,000	0			3,953,000
other interest paid	1,057,000	1,058,000	1,073,000	1,077,000	1,243,000	1,073,000	1,111,000	1,076,000			1,084,000	1,159,000	1,100,000	1,091,000
supplemental schedule of noncash investing and financing activities
contingent consideration acquired
convertible senior notes exchanged for common stock, net of debt issuance costs			0
purchases of property and equipment included in accounts payable and accrued liabilities	88,000	502,000	795,000	-398,000	-1,063,000	1,575,000	-1,868,000	121,000	659,000	2,421,000	539,000	-52,000	605,000	2,705,000

gain on disposal of fixed assets						10,000	12,000					64,000	10,000	-45,000
(amortization of premium) accretion of discount on short-term investments
loss on capped call transaction
inventory write-down
other assets			-67,000	183,000	25,000	-2,216,000	-1,636,000	-421,000	118,000	59,000	187,000	-360,000	62,000	-217,000	84,000	-73,000	146,000	29,000	69,000	429,000	-212,000	1,000	-1,691,000	-29,000	5,000	-62,000	1,332,000	-229,000	-739,000	-160,000		-209,000	-205,000	-163,000					-7,000	-10,000
proceeds from partial unwinding of capped calls related to issuance of convertible senior notes
share purchases under employee stock purchase plan																										902,000	0	2,121,000	0	1,388,000		0				0
payments of employee taxes related to vested restricted stock units
payments related to convertible senior notes
payments related to capped call transactions
net increase in cash, cash equivalents and restricted cash			69,483,000				-15,462,000	14,117,000	17,192,000	-43,127,000	13,507,000	1,415,000	-3,937,000	5,494,000	-12,423,000				15,842,000	-185,980,000	213,360,000	-8,816,000	23,341,000	-425,000	6,347,000	3,897,000	1,318,000	12,337,000	9,354,000	-8,921,000
issuance of common stock related to conversion of convertible senior notes, net of debt issuance costs
noncash lease expense				1,062,000	1,061,000	1,071,000		1,037,000
convertible notes exchanged for common stock, net of debt issuance costs
adjustments to reconcile net income to net cash (used in) provided operating activities:
unrealized foreign currency (gains) losses														-135,000
(accretion of discount) amortization of premium on short-term investments
proceeds from tenant improvement allowance															0	0	12,039,000	629,000
amortization of lease right-of-use assets										1,036,000		1,082,000	1,025,000	1,271,000		1,232,000	1,117,000	1,170,000		1,259,000	1,266,000	1,311,000		1,009,000
interest paid										1,086,000																										56,000	85,000	112,000	140,000	195,000
amortization of the fair market value inventory adjustment
amortization of debt discount
(gain) loss on disposal of fixed assets
change in fair value of cash-settled stock options
proceeds from convertible senior notes																			0	0
payment of convertible senior notes transaction costs																			0	0
purchase of capped calls related to issuance of convertible senior notes																			0	0
taxes paid												132,000	149,000	91,000		87,000				124,000	44,000	250,000		5,000	51,000	40,000		-352,000	362,000	3,000		0	63,000	1,000		1,000	1,000	62,000	11,000	3,000
depreciation and amortization																			7,400,000	7,337,000	7,334,000	7,310,000	3,632,000	946,000	886,000	842,000	1,201,000	1,702,000	1,696,000	1,665,000		1,513,000	1,419,000	1,009,000		1,155,000	1,133,000	1,122,000	1,068,000	1,056,000
amortization of the fair market value inventory adjustment as a result of the avedro merger
amortization of premium (discount) on short-term investments																	260,000	256,000
cash acquired due to acquisition
payment of debt assumed in the avedro merger
shares issued, and replacement awards assumed, in connection with avedro merger
debt assumed in the avedro merger
change in fair value of cash settled stock options																				0	-1,000	-3,171,000
taxes (refunded) paid																		-35,000
amortization of debt discount and deferred financing costs																																							0	0
deferred rent and other liabilities																							1,686,000	1,576,000	1,401,000	689,000	428,000
net cash (used) provided by investing activities
amortization of debt discount and issuance costs																				2,677,000
amortization of discount on short-term investments																				196,000	52,000	-19,000		-77,000	-109,000	-112,000
fair value of cash-settled stock options
amortization of (discount) premium on short-term investments																											-90,000	-70,000
deferred tax asset and receivable
net cash from (used) in investing activities
reduction of liability upon vesting of stock options previously exercised for unvested stock																																1,000	0	3,000		12,000	21,000	21,000	21,000	21,000
amortization of operating lease right-of-use asset																										400,000
change in fair value of stock warrant liability																																				0	0	-43,000	2,000	-31,000
payments of subordinated notes																																							-2,164,000	-2,137,000
proceeds from exercise of stock warrants																																				0			0	50,000
restricted cash																																0	31,000	49,000
deferred rent																													511,000	839,000		239,000	165,000	173,000			-17,000	19,000	30,000	72,000
unrealized foreign currency gains																														-499,000		-324,000	-282,000	-342,000
net cash provided by:
exchange rate changes
net increase in cash and cash equivalents																															5,176,000	5,948,000	4,749,000	2,127,000	1,484,000	-7,351,000	1,947,000	-11,180,000	-71,767,000	-10,805,000
payments of secured notes																																				-2,246,000	-2,219,000	-2,191,000
cash and cash equivalents at beginning of period																																0	0	6,494,000		0	0	21,572,000	0	0
cash and cash equivalents at end of period																																5,948,000	4,749,000	8,621,000		-7,351,000	1,947,000	10,392,000	-71,767,000	-10,805,000
loss on deconsolidation of dose																																							0	0
loss on extinguishment of debt																																							0
purchase of idose product line and related assets from dose medical																																							0	0
proceeds from public offering, net of issuance costs
proceeds from senior secured term and draw-to term loans																																							0
payments of senior secured term and draw-to term loans																																							0
payments of line of credit
unrealized gains on intercompany loans																																					-80,000	-149,000
proceeds from exercise of stock warrant																																						50,000
unrealized losses on intercompany loans
accrued interest expense
proceeds from line of credit
proceeds from issuance of series f preferred stock
payment to acquire treasury stock
purchase of intangible asset in exchange for issuance of subordinated note
purchase of intangible assets in exchange for future payments
conversion of convertible notes and accrued interest into series f convertible preferred stock
conversion of preferred stock into common stock
proceeds from initial public offering, net of issuance costs																																								-1,343,000
net payments of revolving line of credit																																								0
net proceeds from senior secured term and draw-to term loans
issuance costs associated with initial public offering in accounts payable and accrued liabilities

We provide you with 20 years of cash flow statements for Glaukos stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Glaukos stock. Explore the full financial landscape of Glaukos stock with our expertly curated income statements.

The information provided in this report about Glaukos stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.